Cetacaine Topical Anesthetic Gel
NDC Package 10223-0221-1
Package Information
Cetacaine Topical Anesthetic (benzocaine, butamben, and tetracaine hydrochloride) gel is cetacaine Topical Anesthetic Gel is a topical anesthetic indicated for the production of anesthesia of all accessible mucous membrane except the eyes. This formulation utilizes a gel delivery system. Marketed by Cetylite Industries, Inc., this product is identified by NDC 10223-0221.
Identification & Billing
- RxCUI: 209970 - Cetacaine 14 % / 2 % / 2 % Topical Gel
- RxCUI: 209970 - benzocaine 0.14 MG/MG / butamben 0.02 MG/MG / tetracaine 0.02 MG/MG Topical Gel [Cetacaine]
- RxCUI: 209970 - Cetacaine (benzocaine 14 % / butamben 2 % / tetracaine 2 % ) Topical Gel
- RxCUI: 308645 - benzocaine 14 % / butamben 2 % / tetracaine 2 % Topical Gel
- RxCUI: 308645 - benzocaine 0.14 MG/MG / butamben 0.02 MG/MG / tetracaine 0.02 MG/MG Topical Gel
Clinical Specifications
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Ester Local Anesthetic - [EPC] (Established Pharmacologic Class)
- Esters - [CS]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Local Anesthesia - [PE] (Physiologic Effect)
- Standardized Chemical Allergen - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 10223 - Cetylite Industries, Inc.
- 10223-0221 - Cetacaine Topical Anesthetic
- 10223-0221-1 - 1 JAR in 1 BOX / 32 g in 1 JAR
- 10223-0221 - Cetacaine Topical Anesthetic
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 10223-0221-1 identifies a specific commercial package of 1 jar in 1 box / 32 g in 1 jar of Cetacaine Topical Anesthetic, a human prescription drug labeled by Cetylite Industries, Inc.. This product is billed per "GM" gram and contains an estimated amount of 32 billable units per package. This gel is formulated for topical use and contains benzocaine; butamben; tetracaine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cetylite Industries, Inc. on January 01, 1960. The current certification is valid through December 31, 2026.
How is this Cetylite Industries, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 10223022101. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 32 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.